GSDMD and invasive breast carcinoma: GSDMD was significantly upregulated in Bladder Urothelial Carcinoma (BLCA), Breast Cancer (BRCA), and other tumors, while it was notably downregulated in Colon Adenocarcinoma (COAD), Kidney Chromosome (KICH), and several others.